Breaking: CMS Proposes Medicare, Medicaid Coverage for Anti-Obesity Drugs - HME Business

Contributing sentiments towards policy:

56% : "The Biden-Harris Administration has worked to ensure that the Medicare Advantage and Part D prescription drug programs work for people with Medicare, adopted policies holding plans accountable for providing high-quality health care, and protected the sustainability of the Medicare program," said CMS Administrator Chiquita Brooks-LaSure in the announcement.
53% : "This proposed rule continues to build on this work by expanding access to anti-obesity medications for people with Medicare and Medicaid, further addressing prior authorization concerns in Medicare Advantage, and promoting informed choice and transparency by requiring Medicare Advantage plans to share provider directory information on Medicare Plan Finder.
52% : The Centers for Medicare & Medicaid Services (CMS) is proposing Medicare and Medicaid coverage for drugs prescribed to treat obesity, the agency said in a Nov. 26 news announcement.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.